Patents Filed

New Biotic filed 2 provisional patents on blood diagnostic biomarkers to quantify degrees of excitoxicity in ALS and other neurological and psychiatric disorders with the United States Patent and Trademark Office (USPTO).

Read More
New Biotic
Pilot Study

A pilot study on a cohort of 16 ALS patients was initiated. New Biotic, Inc. has a collaboration agreement with the Avera Institute for Human Genetics and the Avera Health system which serve ALS patients throughout SD, portions of MN, IA and NE. Results will be available at the end of April 2018.. 

Read More
New Biotic